Nurix Therapeutics Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2026 to a ratio of 58.49, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the third quarter 2026. Average receivable collection period, for the Nurix Therapeutics Inc in Aug 31 2026 quarter, has decreased to 6 days, compared to 50 days, in the May 31 2026 quarter.

If we take a look into Healthcare sector 23 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 804, from overall ranking in the second quarter 2026 at 847.

What is Receivable Turnover Ratio?
What is Nurix Therapeutics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

NRIX Receivables Turnover Ratio	(Aug 31 2026) III. Quarter	(May 31 2026) II. Quarter	(Feb 28 2026) I. Quarter	(Nov 30 2025) IV. Quarter	(Aug 31 2025) III. Quarter
Y / Y Receivable Change	-	5.26 %	-	-	-
Y / Y Revenue Change	8426.27 %	-79.47 %	-66.12 %	2.21 %	-37.29 %
Receivable Turnover Ratio (TTM)	58.49	7.35	15.11	17.68	17.62
NRIX's Total Ranking	# 804	# 847	# 745	# 720	#
Accounts Receivable average collection period days	6	50	24	21	21
Seq. Receivable Change	40 %	-	-	-	-
Seq. Revenue Change	7342.93 %	44.64 %	-53.95 %	71.99 %	-82.08 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 11
Healthcare Sector	# 24
Overall Market	# 804

Receivable Turnover Ratio Statistics
High	Average	Low
161.77	51.83	7.35
(Feb 29 2024)		(May 31 2026)

NRIX Company Profile • Back to NRIX Efficiency Comparisons • Compare NRIX Receivables Turnover Ratio to its Competitors

Financial Statements
Nurix Therapeutics Inc 's Accounts Receivable	$ 28 Millions	Visit NRIX's Balance sheet
Nurix Therapeutics Inc 's Sales TTM	$ 702 Millions	Visit NRIX's Income Statement
Sources of NRIX's Revenues		Visit NRIX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
NRIX's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
NRIX's Growth Rates	NRIX's Roa	NRIX's Inventory Turnover Ratio	NRIX's Dividend Comparisons
NRIX's Profitability Ratios	NRIX's Roi	NRIX's Asset Turnover Ratio	NRIX's Dividend Growth
NRIX's Valuation Ratios	NRIX's Roe	NRIX's Financial Strength Ratios	NRIX's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Aug 31 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Aug 31 2026	Receivable at quarter ending Aug 31 2026
Kiniksa Pharmaceuticals International Plc	40.65	$ 945.963 Millions	$ 23.272 Millions
Innovage Holding Corp	34.59	$ 1,018.359 Millions	$ 29.443 Millions
Fortrea Holdings Inc	29.58	$ 2,666.700 Millions	$ 90.150 Millions
Wave Life Sciences Ltd	24.65	$ 87.296 Millions	$ 3.541 Millions
Lenz Therapeutics Inc	24.39	$ 12.359 Millions	$ 0.507 Millions
Arvinas Inc	20.06	$ 275.300 Millions	$ 13.725 Millions
Biogen Inc	15.19	$ 10,297.300 Millions	$ 677.900 Millions
Corcept Therapeutics Inc	13.44	$ 963.647 Millions	$ 71.710 Millions
Chemed Corporation	12.65	$ 2,661.041 Millions	$ 210.387 Millions
Caredx Inc	11.75	$ 497.396 Millions	$ 42.330 Millions
Teladoc Health Inc	11.50	$ 2,468.143 Millions	$ 214.604 Millions
Iqvia Holdings Inc	10.43	$ 17,311.000 Millions	$ 1,659.500 Millions
Encompass Health Corporation	9.41	$ 6,338.100 Millions	$ 673.625 Millions
Bausch Health Companies Inc	9.15	$ 11,113.000 Millions	$ 1,215.000 Millions
Pacs Group Inc	8.88	$ 5,705.049 Millions	$ 642.729 Millions
Axogen inc	8.71	$ 266.926 Millions	$ 30.654 Millions
Ensign Group Inc	8.62	$ 5,674.305 Millions	$ 658.477 Millions
Pediatrix Medical Group Inc	8.57	$ 1,959.124 Millions	$ 228.471 Millions
Tenet Healthcare Corp	8.54	$ 22,154.000 Millions	$ 2,593.250 Millions
Brightspring Health Services Inc	8.50	$ 9,479.144 Millions	$ 1,114.763 Millions
Sotera Health Company	8.49	$ 1,230.250 Millions	$ 144.974 Millions
Tactile Systems Technology Inc	8.23	$ 357.176 Millions	$ 43.385 Millions
Penumbra Inc	8.22	$ 1,560.334 Millions	$ 189.735 Millions
Inspire Medical Systems inc	8.15	$ 882.194 Millions	$ 108.207 Millions
Adapthealth Corp	8.14	$ 3,152.043 Millions	$ 387.280 Millions
Rhythm Pharmaceuticals Inc	8.03	$ 280.748 Millions	$ 34.950 Millions
Alphatec Holdings Inc	7.91	$ 839.652 Millions	$ 106.153 Millions
Exelixis Inc	7.89	$ 2,496.861 Millions	$ 316.636 Millions
Henry Schein Inc	7.84	$ 13,734.000 Millions	$ 1,752.000 Millions
Idexx Laboratories Inc	7.78	$ 4,663.675 Millions	$ 599.701 Millions

Date modified: 2026-10-14T16:57:13+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.